Biological function of PDGF-induced PI-3 kinase activity: its role in alpha PDGF receptor-mediated mitogenic signaling

The tyrosine phosphorylation sites in the human alpha PDGF receptor (alpha PDGFR) required for association with PI-3 kinase have been identified as tyrosines 731 and 742. Mutation of either tyrosine substantially reduced PDGF-induced PI-3 kinase activity but did not impair the receptor-mediated mitogenic response. We sought to determine whether PDGF-induced PI-3 kinase activity could be further ablated so as to exclude a low threshold requirement for PDGFR signal transduction. Thus, we mutated both tyrosine 731 and 742 and expressed the double mutant (Y731F/Y742F) in 32D hematopoietic cells. In such transfectants, PDGF induced no detectable receptor-associated or anti-P- Tyr recoverable PI-3 kinase activity. Under the same conditions, neither mobility shift of raf-1 nor tyrosine phosphorylation of either PLC gamma or MAP kinase was impaired. 32D transfectants expressing the double mutant showed wild-type alpha PDGFR levels of mitogenic and chemotactic responses to PDGF. To examine the effect of the double mutation in cells that normally respond to PDGF, we generated chimeras in which the cytoplasmic domains of wild-type alpha PDGFR, Y731F, and Y731F/Y742F were linked to the extracellular domain of colony- stimulating factor-1 (CSF-1) receptor (fms). After introduction of the chimeric receptors into mouse NIH/3T3 fibroblasts, the ability of CSF-1 to stimulate growth of these transfectants was examined. Our data show that all these chimeric receptors exhibited similar abilities to mediate CSF-1-stimulated cell growth. These findings lead us to conclude that PDGF-induced PI-3 kinase activity is not required for PDGF-stimulated mitogenic pathway in both NIH/3T3 fibroblasts and 32D hematopoietic cells.

[1]  T. Fleming,et al.  Independent expression of human alpha or beta platelet-derived growth factor receptor cDNAs in a naive hematopoietic cell leads to functional coupling with mitogenic and chemotactic signaling pathways. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[2]  J. Maller,et al.  Requirement for integration of signals from two distinct phosphorylation pathways for activation of MAP kinase , 1990, Nature.

[3]  James R. Woodgett,et al.  Phosphorylation of c-jun mediated by MAP kinases , 1991, Nature.

[4]  A. Kazlauskas,et al.  Tyrosines 1021 and 1009 are phosphorylation sites in the carboxy terminus of the platelet-derived growth factor receptor beta subunit and are required for binding of phospholipase C gamma and a 64-kilodalton protein, respectively , 1993, Molecular and cellular biology.

[5]  R. Weinberg,et al.  Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation , 1993, Nature.

[6]  D. Morrison,et al.  Direct activation of the serine/threonine kinase activity of raf-1 through tyrosine phosphorylation by the PDGF β-receptor , 1989, Cell.

[7]  S. Rhee,et al.  Platelet-derived growth factor (PDGF) binding promotes physical association of PDGF receptor with phospholipase C. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[8]  P. Libby,et al.  PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells , 1989, Cell.

[9]  L. Cantley,et al.  Oncogenes and signal transduction , 1991, Cell.

[10]  L. Cantley,et al.  Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate , 1988, Nature.

[11]  T. Hunter,et al.  Phospholipase C-γ is a substrate for the PDGF and EGF receptor protein-tyrosine kinases in vivo and in vitro , 1989, Cell.

[12]  G. Panayotou,et al.  Characterization of two 85 kd proteins that associate with receptor tyrosine kinases, middle-T/pp60c-src complexes, and PI3-kinase , 1991, Cell.

[13]  P. Cohen,et al.  Activation of the MAP kinase pathway by the protein kinase raf , 1992, Cell.

[14]  C. Heldin,et al.  Comparison of biological properties and transforming potential of human PDGF-A and PDGF-B chains. , 1988, Science.

[15]  M. White,et al.  Common elements in growth factor stimulation and oncogenic transformation: 85 kd phosphoprotein and phosphatidylinositol kinase activity , 1987, Cell.

[16]  S. Coughlin,et al.  Signal transduction by the platelet-derived growth factor receptor. , 1988, Cold Spring Harbor symposia on quantitative biology.

[17]  Jonathan A. Cooper,et al.  Phosphorylation sites in the PDGF receptor with different specificities for binding GAP and PI3 kinase in vivo. , 1992, The EMBO journal.

[18]  David L. Brautigan,et al.  Raf-1 activates MAP kinase-kinase , 1992, Nature.

[19]  M. Ruggiero,et al.  Macrophage-colony-stimulating factor (CSF-1) induces proliferation, chemotaxis, and reversible monocytic differentiation in myeloid progenitor cells transfected with the human c-fms/CSF-1 receptor cDNA. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[20]  A. Reith,et al.  SH2 domains of the p85 alpha subunit of phosphatidylinositol 3-kinase regulate binding to growth factor receptors , 1992, Molecular and cellular biology.

[21]  T. Fleming,et al.  Transformation of NIH3T3 fibroblasts by an expression vector for the human epidermal growth factor precursor. , 1990, Oncogene.

[22]  C R King,et al.  erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells. , 1987, Science.

[23]  W. Kolch,et al.  Raf-1 protein kinase is required for growth of induced NIH/3T3 cells , 1991, Nature.

[24]  C. Turck,et al.  Distinct phosphotyrosines on a growth factor receptor bind to specific molecules that mediate different signaling pathways , 1992, Cell.

[25]  H. Hanafusa,et al.  Phosphatidylinositol kinase activity associates with viral p60src protein , 1989, Molecular and cellular biology.

[26]  T. Sturgill,et al.  Defective regulation of mitogen-activated protein kinase activity in a 3T3 cell variant mitogenically nonresponsive to tetradecanoyl phorbol acetate , 1991, Molecular and cellular biology.

[27]  S. Pelech,et al.  MAP kinases: charting the regulatory pathways. , 1992, Science.

[28]  A. Ullrich,et al.  Cloning of PI3 kinase-associated p85 utilizing a novel method for expression/cloning of target proteins for receptor tyrosine kinases , 1991, Cell.

[29]  P. Lacal,et al.  Thrombin-dependent association of phosphatidylinositol-3 kinase with p60c-src and p59fyn in human platelets , 1990, Molecular and cellular biology.

[30]  A. Kazlauskas,et al.  Phospholipase C-γ1 and phosphatidylinositol 3 kinase are the downstream mediators of the PDGF receptor's mitogenic signal , 1993, Cell.

[31]  A. Ullrich,et al.  Interaction of phosphatidylinositol 3-kinase-associated p85 with epidermal growth factor and platelet-derived growth factor receptors , 1992, Molecular and cellular biology.

[32]  V. Fried,et al.  cDNA cloning of a Novel 85 kd protein that has SH2 domains and regulates binding of PI3-kinase to the PDGF β-receptor , 1991, Cell.

[33]  E. Stanley.  Macrophage Colony-Stimulating Factor (CSF-1) , 1998 .

[34]  T. Fleming,et al.  PDGF induction of tyrosine phosphorylation of GTPase activating protein , 1989, Nature.

[35]  S. Volinia,et al.  Phosphatidylinositol 3-kinase: Structure and expression of the 110 kd catalytic subunit , 1992, Cell.

[36]  A. Ullrich,et al.  Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells , 1987, Cell.

[37]  T. Pawson,et al.  The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1 , 1993, Nature.